StockData
Bausch Health Companies Inc. logo

Bausch Health Companies Inc. (BHC) stock

BHCNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3077% below fair value
$8.35+0.10 (+1.21%)

Close on Nov 13, 2026Market cap $3.13BP/E –Yield –

Bausch Health Companies EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Bausch Health Companies's EV/EBITDA was 11.2× on Nov 11, 2026, against 7.4× a year earlier. Over the last 5 years it ranged from 7.3× to 18.7×, with a median of 10.6×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202611.2×+3.8
2025Dec 31, 20257.4×−1.9
2024Dec 31, 20249.4×−6.0
2023Dec 29, 202315.4×+5.6
2022Dec 30, 20229.8×−8.9
2021Dec 31, 202118.7×−2.0
2020Dec 31, 202020.6×+9.6
2019Dec 31, 201911.0×−72.9
2018Dec 31, 201883.9×+73.8
2017Dec 29, 201710.1×−5.0
2016Dec 30, 201615.1×−0.6
2015Dec 31, 201515.7×−3.7
2014Dec 31, 201419.4×−27.7
2013Dec 31, 201347.1×+23.0
2012Dec 31, 201224.2×−51.0
2011Dec 30, 201175.2×+50.4
2010Oct 29, 201024.8×−13.6
2009Dec 31, 200938.4×–

More Bausch Health Companies figures

See a number that looks wrong?